Adherence to Antimalarial Drug Policy Among Doctors in Delta State, Nigeria: Implications for Malaria Control

Overview

Journal Ghana Med J

Specialty General Medicine

Date 2019 Sep 5

PMID 31481806

Citations 4

Authors

Irikefe P Obiebi

Affiliations

Soon will be listed here.

Abstract

Background: Malaria is a public health problem compounded with a widespread emergence of drug-resistant Plasmodium falciparum which necessitated the formulation of a new antimalarial drug policy (AMP).

Objective: This study was designed to assess adherence to the policy among physicians in health facilities in Delta state, Nigeria.

Design: Cross-sectional, analytic study. Data were collected with a semi-structured questionnaire.

Setting: Two secondary and one tertiary health facilities in Delta State, Nigeria.

Participants: Physicians selected with a simple random technique from the facilities.

Main Outcome Measures: Prescribing pattern of antimalarial drugs and adherence to WHO treatment guideline among doctors.

Results: Majority (90.8%) of respondents believed the antimalarial policy (AMP) should be strictly adhered to, although three-fifth (61.0%) of them rated its performance as poor. The level of adherence to the national antimalarial drug policy was high (78.5%) as most doctors prescribed Arthemeter-Lumefantrine, AL for uncomplicated malaria however barely two-fifth (35.4%) adhered to prescribing injectable Artesunate for complicated malaria. AL, (71.9%) was the most prescribed antimalarial drug for uncomplicated malaria The most prescribed antimalarial drugs for complicated malaria was artesunate (40.0%) followed by quinine (27.6%) and artemether (26.7%); although, chloroquine was also prescribed.

Conclusion: The level of adherence to AMP among doctors was sub-optimal. Continuous education of doctors on the new AMP is needed to achieve malarial control.

Funding: No funding was received for this study.

Citing Articles

Application of mathematical modelling to inform national malaria intervention planning in Nigeria.

Ozodiegwu I, Ambrose M, Galatas B, Runge M, Nandi A, Okuneye K Malar J. 2023; 22(1):137.

PMID: 37101146 PMC: 10130303. DOI: 10.1186/s12936-023-04563-w.

Evaluation of rational prescribing in a hospital paediatric outpatient clinic in Nigeria.

Okoye B, Udemba J, Ndugba C, Okonkwo J, Obed E BMJ Paediatr Open. 2023; 6(1).

PMID: 36645753 PMC: 9562308. DOI: 10.1136/bmjpo-2022-001585.

Knowledge and practices regarding malaria and the National Treatment Guidelines among public health workers in Equatorial Guinea.

Blanco M, Suarez-Sanchez P, Garcia B, Nzang J, Ncogo P, Riloha M Malar J. 2021; 20(1):21.

PMID: 33413402 PMC: 7789308. DOI: 10.1186/s12936-020-03528-7.

Assessment of Use of National Guidelines for Malaria Case Management among Pediatric Resident Doctors Attending an Update Course in Benin City, Nigeria.

Nwaneri D, Sadoh A, Ibadin M Niger Med J. 2020; 61(2):78-83.

PMID: 32675899 PMC: 7357802. DOI: 10.4103/nmj.NMJ_72_19.

References

Dodoo A, Fogg C, Asiimwe A, Nartey E, Kodua A, Tenkorang O . Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy. Malar J. 2009; 8:2. PMC: 2647941. DOI: 10.1186/1475-2875-8-2. View

Yeung S, White N . How do patients use antimalarial drugs? A review of the evidence. Trop Med Int Health. 2005; 10(2):121-38. DOI: 10.1111/j.1365-3156.2004.01364.x. View

Price R, Dorsey G, Ashley E, Barnes K, Baird J, DAlessandro U . World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Malar J. 2007; 6:119. PMC: 2008205. DOI: 10.1186/1475-2875-6-119. View

Riley C, Dellicour S, Ouma P, Kioko U, Kuile F, Omar A . Knowledge and Adherence to the National Guidelines for Malaria Case Management in Pregnancy among Healthcare Providers and Drug Outlet Dispensers in Rural, Western Kenya. PLoS One. 2016; 11(1):e0145616. PMC: 4720358. DOI: 10.1371/journal.pone.0145616. View

Tiono A, Ouedraogo A, Bougouma E, Diarra A, Konate A, Nebie I . Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens. Malar J. 2009; 8:224. PMC: 2768741. DOI: 10.1186/1475-2875-8-224. View

Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J . Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Am J Trop Med Hyg. 2004; 71(5):525-30. View

Bardaji A, Sigauque B, Sanz S, Maixenchs M, Ordi J, Aponte J . Impact of malaria at the end of pregnancy on infant mortality and morbidity. J Infect Dis. 2011; 203(5):691-9. PMC: 3071276. DOI: 10.1093/infdis/jiq049. View

Yeung S, Pongtavornpinyo W, Hastings I, Mills A, White N . Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am J Trop Med Hyg. 2004; 71(2 Suppl):179-86. View

Ezedudu C, Ebenebe J, Chukwuka J, Ugochukwu E, Amilo G, Okorie O . Malaria parasitaemia among febrile under-five children at Nnamdi Azikiwe University Teaching Hospital, Nnewi, South-East, Nigeria. Niger J Med. 2018; 25(2):113-18. View

10.

Meremikwu M, Okomo U, Nwachukwu C, Oyo-Ita A, Eke-Njoku J, Okebe J . Antimalarial drug prescribing practice in private and public health facilities in South-east Nigeria: a descriptive study. Malar J. 2007; 6:55. PMC: 1867820. DOI: 10.1186/1475-2875-6-55. View

11.

Gerstl S, Dunkley S, Mukhtar A, Baker S, Maikere J . Successful introduction of artesunate combination therapy is not enough to fight malaria: results from an adherence study in Sierra Leone. Trans R Soc Trop Med Hyg. 2010; 104(5):328-35. DOI: 10.1016/j.trstmh.2009.12.008. View

12.

Souares A, Lalou R, Sene I, Sow D, Le Hesran J . Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal. Trans R Soc Trop Med Hyg. 2008; 102(8):751-8. DOI: 10.1016/j.trstmh.2008.05.016. View

13.

Barnes K, Durrheim D, Little F, Jackson A, Mehta U, Allen E . Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med. 2005; 2(11):e330. PMC: 1240068. DOI: 10.1371/journal.pmed.0020330. View

14.

Kachur S, Khatib R, Kaizer E, Fox S, Abdulla S, Bloland P . Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am J Trop Med Hyg. 2005; 71(6):715-22. View

15.

Mace K, Mwandama D, Jafali J, Luka M, Filler S, Sande J . Adherence to treatment with artemether-lumefantrine for uncomplicated malaria in rural Malawi. Clin Infect Dis. 2011; 53(8):772-9. DOI: 10.1093/cid/cir498. View

16.

Wasunna B, Zurovac D, Goodman C, Snow R . Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine. Malar J. 2008; 7:29. PMC: 2266770. DOI: 10.1186/1475-2875-7-29. View

17.

Koram K, Abuaku B, Duah N, Quashie N . Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. Acta Trop. 2005; 95(3):194-203. DOI: 10.1016/j.actatropica.2005.06.018. View

18.

Bell D, Wootton D, Mukaka M, Montgomery J, Kayange N, Chimpeni P . Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi. Malar J. 2009; 8:204. PMC: 2744923. DOI: 10.1186/1475-2875-8-204. View

19.

Cockburn R, Newton P, Agyarko E, Akunyili D, White N . The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med. 2005; 2(4):e100. PMC: 1062889. DOI: 10.1371/journal.pmed.0020100. View